Hybrid Conferencee

International Conference on Hematology and Clinical Trials (ICHCT - 26)

5th - 6th September 2026 | Melbourne, Australia

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Melbourne. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Melbourne event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Melbourne conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Melbourne, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Melbourne."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Hematology Clinical Trials

This track will explore recent innovations in the design and execution of clinical trials within hematology. Emphasis will be placed on methodologies that enhance patient recruitment and retention, as well as strategies to improve trial outcomes.

Track 02

Molecular Diagnostics in Hematology

This session will focus on the latest advancements in molecular diagnostics that are transforming the landscape of hematological disorders. Participants will discuss the implications of these technologies for early detection and personalized treatment approaches.

Track 03

Laboratory Innovations in Hematology

This track will highlight cutting-edge laboratory techniques and technologies that are improving diagnostic accuracy and efficiency in hematology. Discussions will include automation, high-throughput screening, and novel assay development.

Track 04

Therapeutic Strategies in Hematological Disorders

This session will examine emerging therapeutic strategies for the treatment of various hematological conditions. Topics will include novel drug development, combination therapies, and the role of immunotherapy.

Track 05

Translational Research in Hematology

This track will delve into the translation of laboratory findings into clinical applications in hematology. Researchers will present their work on bridging the gap between basic science and patient care.

Track 06

Understanding Disease Mechanisms in Hematology

This session will focus on the underlying mechanisms of hematological diseases, including genetic, epigenetic, and environmental factors. Insights gained from this research are crucial for developing targeted therapies.

Track 07

Clinical Outcomes in Hematology Trials

This track will evaluate the clinical outcomes of recent hematology trials, providing insights into efficacy and safety profiles of new treatments. Discussions will also cover the impact of these outcomes on clinical practice.

Track 08

Biomarker Discovery in Hematology

This session will explore the identification and validation of biomarkers that can predict treatment response and disease progression in hematological disorders. The role of biomarkers in personalized medicine will be a key focus.

Track 09

Patient-Centered Care in Hematology

This track will emphasize the importance of patient-centered approaches in hematology care and clinical trials. Discussions will include strategies for enhancing patient engagement and improving quality of life.

Track 10

Ethical Considerations in Hematology Research

This session will address the ethical challenges and considerations specific to conducting research in hematology. Topics will include informed consent, patient safety, and the ethical implications of novel therapies.

Track 11

Global Perspectives on Hematology Clinical Trials

This track will provide a platform for discussing the global landscape of hematology clinical trials, including challenges and opportunities in diverse populations. Participants will share insights on international collaboration and regulatory considerations.